logo

For the Inventor, By the Inventor

New York, NY, United States of America

Olatec Therapeutics LLC

Calculating rank
USPTO Granted Patents = 31


Trademarks = 2

Forward Citations = 21

Loading Chart...
Loading Chart...

10 inventors (with patents filed for the assignee):

goldMedal Joseph St Laurent (23 out of 46 patents)

silverMedal Gerald S Jones (18 out of 36 patents)

bronzeMedal David M Bresse (15 out of 20 patents)

4.  Scott A Goodrich (9 out of 22 patents)

5.  Charles A Dinarello (7 out of 45 patents)

6.  Carlo Marchetti (4 out of 4 patents)

7.  George M Shopp (1 out of 7 patents)

8.  David M Breese (1 out of 1 patent)

9.  Isak Tengesdal (1 out of 1 patent)

10.  Marc Y Donath (1 out of 1 patent)


Core Competencies:
Breast Cancer
Diabetes
Cardiovascular Diseases
Melanoma
Alzheimer's Disease
Inflammation
Pain Treatment
Multiple Sclerosis
Pharmaceutical Composition
Sulfonylpropionitrile
Skin Inflammatory Diseases
Nitrile Compounds

31 patents:

1. 12582628 - METHODS FOR TREATING BREAST CANCER (2026-03-24),
2. 12569463 - Method for treating diabetes (2026-03-10),
3. 12318361 - Methods for treating cardiovascular diseases (2025-06-03),
4. 11857529 - Methods for treating melanoma (2024-01-02),
5. 11576888 - Methods for treating cardiovascular diseases (2023-02-14),
6. 11517554 - Method for preventing or treating Alzheimer's disease (2022-12-06),
7. 11229620 - 3-methanesulfonylpropionitrile for treating inflammation and/or pain (2022-01-25),
8. 10751316 - Pharmaceutical composition for treating inflammation and pain (2020-08-25),
9. 10548870 - Method for treating multiple sclerosis (2020-02-04),
10. 10500184 - 3-methanesulfonylpropionitrile for treating inflammation and/or pain (2019-12-10),
11. 10441555 - Pharmaceutical composition (2019-10-15),
12. 10273203 - Deuterated 3-methanesulfonylpropionitrile (2019-04-30),
13. 10172822 - Pharmaceutical use of 3-benzylsulfonylpropionitrile (2019-01-08),
14. 10143675 - Pharmaceutical composition for treating inflammation and pain (2018-12-04),
15. 10080735 - 3-methanesulfonylpropionitrile for treating inflammation and/or pain (2018-09-25),
Company Overview
Olatec Therapeutics LLC is a biopharmaceutical company based in New York, specializing in the development of innovative therapies for various medical conditions. The organization focuses on leveraging advanced research in the fields of immunology and inflammation to create novel treatment options. Olatec is committed to addressing unmet medical needs through its proprietary technologies, aiming to improve patient outcomes and enhance quality of life. Its work is characterized by a dedication to scientific excellence and a patient-centered approach.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

31 Patents

#282 in New York, NY

#657 in New York

#10,959 in US

#21,334 in the World

New York, NY (US)
New York, NY, United States of America

Olatec Therapeutics LLC

Forward Citations = 21

10 inventors:

goldMedal Joseph St Laurent (23 out of 46 patents)

silverMedal Gerald S Jones (18 out of 36 patents)

bronzeMedal David M Bresse (15 out of 20 patents)

4.  Scott A Goodrich (9 out of 22 patents)

5.  Charles A Dinarello (7 out of 45 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Olatec Therapeutics LLC. Retrieved from https://idiyas.com/company/olatec-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…